11th Edition of International Conference on
Neurology and Neurological Disorders
June 05-07, 2025 | Rome, Italy
Molecular Neuroscience
Molecular neuroscience delves into the molecular and cellular mechanisms that govern the function of the nervous system. By studying neurotransmission, signal transduction, and neuronal development at the molecular level, researchers aim to uncover the processes underlying neurological diseases such as Alzheimer's, Parkinson's, and epilepsy. Advances in molecular techniques, including CRISPR gene editing and single-cell RNA sequencing, are enabling a more detailed understanding of how molecular changes affect brain function and behavior. This field also explores the role of proteins, lipids, and small molecules in neuronal communication, synaptic plasticity, and neuroinflammation. As these insights translate into new therapeutic targets, molecular neuroscience holds the key to developing more effective treatments for a variety of neurological disorders.
Ken Ware
NeuroPhysics Therapy Institute, Australia
Robert B Slocum
University of Kentucky HealthCare, United States
Luiz Moutinho
University of Suffolk, United Kingdom
David Lominadze
University of South Florida, United States
Dixie J Woolston
Mayo Clinic Arizona/Scottsdale, United States
David Sperbeck
Private Practice, United States
Sang Hie Lee
University of South Florida, United StatesSubmit your abstract Today
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom